Catalyst Wire Dossier Catalyst Wire Dossier

Tonlamarsen

· Kardigan, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tonlamarsen, covering 2026-03-31 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital [Phase 2]

See pricing